• Facebook
  • Twitter
  • Linkedin
Oslo Cancer Cluster - Innovation Park
  • About
    • A power centre
    • Board
    • Construction stage 2
  • Companies
  • News
  • Events
  • Property
    • Property Overview
    • The building
    • Leasing
    • Services
    • Floor plans
    • Technical solutions
    • Illustrations
  • Contact
  • Menu

Archive for: Company

You are here: Home / Property / Company

Syklotronsenteret

Zelluna

Ultimovacs

Logo Cancer Registry of Norway

The Norwegian Cancer Registry

Page 1 of 3123

Pages

  • A power centre
  • About
  • Amenities
  • Board
  • Catering
  • Companies
  • Construction stage 2
  • Contact
  • Events
  • Feed-test
  • Home
  • News
  • Parking
  • Privacy notice
  • Property
  • startpage
  • Team

Categories

  • #OIW2017
  • 100 episodes
  • Acapo
  • Access to capital
  • advanced light microscopy
  • AI
  • Allison
  • anette weyergang
  • Arctic Pharma
  • arendalsuka19
  • Artemida
  • artificial intelligence
  • astrazeneca
  • award
  • AXL-kinase inhibitor
  • bemcentinib
  • BerGen Bio
  • bergenbio
  • bile duct cancer
  • BIO
  • biobanks
  • biochemistry
  • biotechnology
  • biotechs
  • bjørn klem
  • bladder cancer
  • BLC
  • board member
  • board members
  • breakfast meeting
  • Breast Cancer
  • Bristol-Myers Squibb
  • Business development
  • cancer
  • cancer care
  • cancer clusters
  • Cancer Crosslinks
  • Cancer Crosslinks 2019
  • cancer crosslinks 2020
  • cancer drug fund
  • cancer medicine
  • cancer patient
  • cancer patients
  • cancer research
  • cancer treatments
  • cancer vaccine
  • CAR T cells
  • car t therapy
  • CAR T-cell therapy
  • Cathrine M. Lofthus
  • CCB
  • cell biology
  • cell therapy
  • Centre for cancer biomedicine
  • cervical cancer
  • chemotherapy
  • clinical collaboration
  • clinical research
  • clinical study
  • clinical trial
  • Clinical Trial Unit
  • Clinical Trials
  • Cluster Collaborations
  • clusters
  • collaboration
  • conference
  • connect
  • consulting
  • corona
  • curida
  • Dehns
  • digibcube
  • digitalisation
  • Digitalization
  • DNV GL
  • domore!
  • drug
  • Dynabeads
  • E-health
  • ECCP
  • education
  • educational agreement
  • EHIN
  • EHiN 2019
  • einarsson
  • Eisai
  • embassy of denmark
  • erc grant
  • European Cancer Cluster Partnering
  • evaluation
  • excellent
  • experimental cancer therapy
  • External
  • financial scheme
  • financing
  • forskerlinje
  • fund
  • funding
  • funding opportunity
  • genes
  • genomics
  • Giamag
  • Gunhild M. Mælandsmo
  • håkon haugli
  • health
  • Health data
  • health industry
  • health innovation
  • health mentor program
  • health services
  • health technology assessment
  • helsedata
  • helsementor
  • helsemyggordningen
  • Helsenæring
  • Helsenæringens verdi
  • hematology
  • Herceptin
  • Hexvix
  • Horizon 2020
  • Høringsinnspill
  • HPV
  • HTA
  • ICCS
  • ICT
  • immun-oncology
  • immune
  • immune checkpoint inhibitor
  • Immunitrack
  • Immuno-Oncology
  • immunology
  • immunotherapy
  • impress
  • iNANOD
  • Incubator
  • inkubator
  • Innovasjon Norge
  • Innovasjonsparken
  • innovation
  • innovation norway
  • InnovationPark
  • Institute for cancer research
  • International
  • international womens day
  • Investinor
  • investment
  • investoropportunities
  • investors
  • IRW Consulting
  • iselin nybø
  • James Allison
  • Jon Amund Kyte
  • kaare norum
  • Kadycla
  • kaiku health
  • kapecitabine
  • Ketil Widerberg
  • KEYTRUDA
  • king hussein cancer centre
  • king hussein cancer foundation
  • Kirsten Sandvig
  • kongsberg beam technology
  • laboratory
  • lapatinib
  • life science
  • life talents
  • Logistics
  • lung cancer
  • Lytix Biopharma
  • Machine-learning
  • malignant melanoma
  • medical device
  • medical nutrition
  • meeting places
  • Melanoma
  • Members
  • mentor
  • mentorprogram
  • metastasis
  • MyHere
  • Nacamed
  • nanomedicine
  • Nansen prize
  • næringsdepartementet
  • nec corporation
  • neuroscience
  • New cancer research
  • new cancer treatment
  • new cancer treatments
  • new members
  • new memebers
  • News
  • NLS Days
  • nls days 2019
  • NLSDays
  • Nobel Prize
  • NOME
  • Nordic collaboration
  • Nordic Life Science Days
  • nordic nanovector
  • Norgenotech
  • norway
  • Norwegian Cancer Society
  • Norwegian research Council
  • olweus
  • oncoimmunity
  • Oncoinvent
  • oncology
  • oncology clinical trials
  • oncology conference
  • oncolytic peptide
  • OPINION
  • Oslo Cancer Cluster
  • Oslo Cancer Cluster Incubator
  • Oslo Cancer Cluster Innovation Park
  • Oslo Cancer Cluster Innovation Park. radiumhsopitalets legater
  • Oslo Cancer Cluster Innovationpark
  • oslo stock exchange
  • oslo university hospital
  • Other
  • Padmanee Sharma
  • pancreatic cancer
  • partnering
  • Partnership
  • pathology
  • patient involvement
  • patients
  • PCI
  • PCI Biotech
  • PCI technology
  • pdt
  • Per Morten Sandset
  • Permides
  • Personalis
  • personalised medicine
  • Personalized Cancer Medicine
  • personalized medicine
  • pharma-TV
  • pharmaconutrition
  • photocure
  • photodynamic technology
  • podcast
  • Political input
  • Precision Medicine
  • precision oncology
  • prediction tool
  • press seminar
  • prisvinnere
  • profag
  • project
  • Proton therapy
  • q3 report
  • R&D
  • R&D Network
  • R&D Network Meetings
  • radforsk
  • Radium
  • radium hospital
  • Radium Hospital Foundation
  • Radium Hospital Hospital
  • Radiumhospitalet
  • Report
  • research
  • research and development
  • resistant mechanism
  • revenue growth
  • Roche
  • Sanofi
  • Sarcoma
  • School collaboration
  • seminar
  • sharelab
  • simone mester
  • Siva
  • skin cancer
  • skolesamarbeid
  • smartfish
  • SPARK
  • SPARK Scholars
  • Stanford
  • start-up
  • Start-ups
  • startups
  • Statsbudsjettet
  • summer meeting
  • summer party
  • symptom monitoring
  • t cell
  • t cell therapy
  • Talents of Tomorrow
  • Targovax
  • tech
  • Thermo Fisher Scientific
  • third quarter
  • thomas andersson
  • tv
  • Ugelstad-kulene
  • uio
  • ullern
  • Ullern High School
  • Ullern Upper Secondary School
  • Ullern Videre
  • ullern videregående
  • ullern videregående skole
  • Ultimovacs
  • Uncategorized
  • university of oslo
  • Vaccibody
  • Venstre
  • warburg effect
  • WLC
  • workshop

Archive

  • July 2021
  • June 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • January 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • April 2016
  • March 2016
  • February 2016
  • January 2016
  • December 2015
  • November 2015
  • October 2015
  • September 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
  • March 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • August 2014
  • July 2014
  • June 2014
  • May 2014
  • April 2014
  • February 2014
  • January 2014
  • December 2013

CONTACT

Oslo Cancer Cluster Innovation Park
Ullernchauséen 64/66
0379 Oslo
Norway

Contact us >

Info

Oslo Cancer Cluster Innovation Park opened in May 2015.

The Innovation Park brings together the oncology-value chain from basic research to industry within the Oslo-area.

Our vision is to create Europe's leading environment for education, research and industry within oncology, shortening the development time of new cancer treatments.

About

  • A power centre
  • Board
  • Construction stage 2
To OCC
To Oslo Cancer Cluster Incubator
© Copyright - Oslo Cancer Cluster - Innovation Park - Organization number: 991068503 - Design by Fete Typer - Privacy notice and cookies
Scroll to top